Results 221 to 230 of about 93,624 (253)
Some of the next articles are maybe not open access.
Antibiotic-resistant enterococci
Journal of Hospital Infection, 1992Enterococci have emerged as an important cause of nosocomial infection. Successful antibiotic treatment of serious enterococcal infection usually depends on the synergistic bactericidal effect achieved by the combination of a cell wall-active agent, such as ampicillin or a glycopeptide, and an aminoglycoside.
J W, Gray, S J, Pedler
openaire +2 more sources
International Journal of Antimicrobial Agents, 2007
Besides Staphylococcus aureus, other Gram-positive bacteria have become multidrug-resistant and cause therapeutic problems, particularly amongst hospitalised patients. The acquisition of vancomycin resistance by strains of Enterococcus faecium and Enterococcus faecalis is of particular concern and has resulted in treatment failures.
openaire +2 more sources
Besides Staphylococcus aureus, other Gram-positive bacteria have become multidrug-resistant and cause therapeutic problems, particularly amongst hospitalised patients. The acquisition of vancomycin resistance by strains of Enterococcus faecium and Enterococcus faecalis is of particular concern and has resulted in treatment failures.
openaire +2 more sources
Biofilm-associated infection by enterococci
Nature Reviews Microbiology, 2018Jun-Hong Ch’ng +4 more
semanticscholar +1 more source
Risks associated with enterococci as probiotics.
Food Research International, 2020Xingmin Wang, Yonghong Yang, M. Huycke
semanticscholar +1 more source
Ampicillin-resistant enterococci
Journal of Clinical Microbiology, 1990E, Cercenado +3 more
openaire +2 more sources

